PHASE GENOMICS, INC.
Seattle, WA · Founded 2015 · CIK 0001722760 · Medtech
Hi-C-based proximity ligation sequencing platform for detecting chromosomal aberrations in formalin-fixed paraffin-embedded (FFPE) tumor tissue
phasegenomics.com →- Grants
- $18M
- 20 awards
- Sector median: 1
- Raised
- $5.8M
- 2 Form D · Mar 2023
- 43 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 1 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Deconvolution and Assembly of Metgenomes Using Chromatin Conformation Capture | $216,192 | |
| Private capital raised | Form D · SEC | $1,000,001 | |
| Federal grant | Department of Health and Human Services · Phase II · Deconvolution and Assembly of Metagenomes Using Chromatin Conformation Capture | $1,499,644 | |
| Federal grant | Department of Health and Human Services · Phase II · Deconvolution and Assembly of Metagenomes Using Chromatin Conformation Capture | $749,394 | |
| Federal grant | Department of Health and Human Services · Phase II · A proximity ligation method to track mobile element hosts | $1,494,834 | |
| Federal grant | Department of Health and Human Services · Phase II · A next-generation method for cytogenomics using Hi-C proximity ligation sequencing | $249,984 | |
| Federal grant | Department of Health and Human Services · Phase I · Next generation cytogenomics using proximity ligation sequencing | $249,984 | |
| Federal grant | Department of Health and Human Services · Phase II · A proximity ligation method to track mobile element hosts | $895,817 | |
| Federal grant | Department of Health and Human Services · Phase II · A method for the culture-free discovery and host affiliation of novel viruses from metagenomic samples | $1,640,758 | |
| Federal grant | Department of Agriculture · Strain-level Diagnostics Of Fungal Crop Pathogens Enabled By Fully-phased Isolate Genomes | $99,866 | |
| Federal grant | Department of Health and Human Services · Phase II · A next-generation method for cytogenomics using Hi-C proximity ligation sequencing | $1,675,858 | |
| Federal grant | Department of Health and Human Services · Phase II · A method for the culture-free discovery and host affiliation of novel viruses from metagenomic samples | $820,379 | |
| Federal grant | Department of Health and Human Services · Phase II · A next-generation method for cytogenomics using Hi-C proximity ligation sequencing | $837,867 | |
| Federal grant | Department of Health and Human Services · Phase II · Therapeutic phage host-range prediction using proximity-guided metagenomics and artificial intelligence | $1,991,746 | |
| Private capital raised | Form D · SEC | $4,754,364 | |
| Federal grant | Department of Health and Human Services · Phase II · Therapeutic phage host-range prediction using proximity-guided metagenomics and artificial intelligence | $995,873 | |
| Federal grant | Department of Health and Human Services · Phase I · Biological validation of phage host-range identified by proximity guided metagenomics | $299,132 | |
| Federal grant | Department of Health and Human Services · Phase II · AI-based AML risk stratification using next generation cytogenomics | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Chromosomal aberration detection in FFPE tissue using proximity ligation sequencing | $858,324 | |
| Federal grant | Department of Health and Human Services · Phase II · AI-based AML risk stratification using next generation cytogenomics | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Chromosomal aberration detection in FFPE tissue using proximity ligation sequencing | $1,141,676 | |
| Federal grant | Department of Health and Human Services · Phase I · Harnessing mRNA Vaccine Technology for Precision Antimicrobial Delivery | $299,163 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1150 | Valisure | — | $9.8M |
| 1151 | Envision Genomics | — | $160K |
| 1152 | Vivifi Medical LLC | — | — |
| 1153 | PHASE GENOMICS, INC. | — | $5.8M |
| 1154 | CorVent Medical, Inc. | — | $13M |
| 1155 | Ischemia Care, LLC | — | $11M |
| 1156 | EarliTec Diagnostics, Inc. | — | $30M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ivan LiachkoDirector · Executive Officer · Promoter
- Shawn SullivanExecutive Officer · Promoter
- Kayla YoungExecutive Officer
Patents
- Method For The Clustering Of Dna Sequencesapplication
- A Method For The Clustering Of Dna Sequencesgranted
- Chromosome Conformation Capture From Tissue Samplesapplication
- Systems And Methods For Karyotyping By Sequencingapplication
- Chomosome Conformation Capture From Tissue Samplesapplication
- Systems And Methods For Karyotyping By Sequencingapplication
- A Method For The Clustering Of Dna Sequencesapplication
- Lysins For Treatment Of Bacterial Infectionapplication
- Method For The Clustering Of Dna Sequencesapplication
- Lysins For Treatment Of Bacterial Infectionapplication
- Chomosome Conformation Capture From Tissue Samplesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.